Aspergillosis

  • Andreas H. Groll
  • Thomas J. Walsh

Abstract

Moulds of the genus Aspergillus are among the most common fungi of all environments. They grow well in soil and decaying vegetation and can be found on all types of organic debris. In hospitals, ventilation systems and dust associated with construction activity have been implicated as the main habitats of the organism.

Keywords

Acute Leukemia Invasive Aspergillosis Chronic Granulomatous Disease Invasive Fungal Infection Aspergillus Species 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rippon JW: Aspergillosis. In Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes. Edited by Rippon JW. Philadelphia: WB Saunders; 1988: 618–650.Google Scholar
  2. 2.
    Cohen J: Clinical manifestations and management of aspergillosis in the compromised patient. In Fungal Infections in the Compromised Patient. Edited by Warnock DW, Richardson MD. Chichester: John Wiley and Sons; 1991: 117–152.Google Scholar
  3. 3.
    Groll AH, Shah PM, Mentzel C, Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996, 33:23–32.Google Scholar
  4. 4.
    Pannuti CS, Gingrich RD, Pfaller MA, Wenzel RP: Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol 1991, 9: 77–84.PubMedGoogle Scholar
  5. 5.
    Wald A, Leisenring W, vanBurik JA, Bowden RA: Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997, 175: 1459–1466.PubMedCrossRefGoogle Scholar
  6. 6.
    Anaissie E: Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992, 14 (suppl 1): S43 - S53.PubMedCrossRefGoogle Scholar
  7. 7.
    Weinberger M, Elattor I, Marshall D, et al.: Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as major cause of death. Medicine 1992, 71: 24–43.PubMedGoogle Scholar
  8. 8.
    Hibberd PL, Rubin RH: Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994, 19 (suppl 1): 33–40.CrossRefGoogle Scholar
  9. 9.
    Khoo SH, Denning DW: Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994, 19 (suppl 1): 41–48.CrossRefGoogle Scholar
  10. 10.
    Shetty D, Giri N, Gonzalez CE, Invasive aspergillosis in human immunodeficiency virus infected children. Pediatr Infect Dis J 1997,16:216–221.Google Scholar
  11. 11.
    Larone DH: Medically Important Fungi: A Guide to Identification, 2nd ed. Edited by Larone DH. Amsterdam: Elsevier Science Publishing; 1991: 90–91.Google Scholar
  12. 12.
    Walsh TJ, Dixon DM: Spectrum of mycoses. In Medical Microbiology, 4th ed. Edited by Baron S. New York: Churchill Livingstone; 1996: 919–925.Google Scholar
  13. 13.
    Bayer AS: Diagnosis of aspergillosis. In Aspergillosis. Edited by Al-Doory Y, Wagner GE. Springfield: Charles Thomas Publisher; 1985: 129–146.Google Scholar
  14. 14.
    Malo JL: Allergic bronchopulmonary aspergillosis. In Aspergillosis. Edited by Al-Doory Y, Wagner GE. Springfield: Charles Thomas Publisher; 1985: 79–95.Google Scholar
  15. 15.
    Kryda MJ, Marx JJ, Emanuel DA: Farmer’s lung disease and other hypersensitivity pneumonitides. In Fungal Diseases of the Lung, 2nd ed. Edited by Sarosi GA, Davies SF. New York: Raven Press; 1993: 215–227.Google Scholar
  16. 16.
    Bardana EJ: Pulmonary aspergillosis. In Aspergillosis. Edited by Al-Doory Y, Wagner GE. Springfield: Charles Thomas Publisher; 1985: 43–78.Google Scholar
  17. 17.
    Daly RC: Pulmonary aspergilloma: results of surgical treatment. J Thorac Cardiovasc Surg 1986, 92: 981–998.PubMedGoogle Scholar
  18. 18.
    Patterson TF: Commentary: management of Aspergillus fungus ball-role of antifungal therapy. Infect Dis Clin Pract 1998, 7: 127–128.Google Scholar
  19. 19.
    Denning DW: Diagnosis and management of invasive aspergillosis. Curr Clin Top Infect Dis 1996, 16: 277–299.PubMedGoogle Scholar
  20. 20.
    Diamond RD: Invasive aspergillosis: host defenses. Recent Results Cancer Res 1993, 132: 109–115.PubMedCrossRefGoogle Scholar
  21. 21.
    Schaffner A, Douglas H, Braude A: Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982, 69: 617–631.PubMedCrossRefGoogle Scholar
  22. 22.
    Roilides E, Uhlig K, Venzon D, et al.: Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993, 61: 1185–1193.PubMedGoogle Scholar
  23. 23.
    Berenguer J, Allende MC, Lee JW, et al.: Pathogenesis of pulmonary aspergillosis: granulocytopenia vs. cyclosporine and methylprednisoloneinduced immunosuppression. Am J Respir Crit Care Med 1995, 152: 1079–1086.PubMedCrossRefGoogle Scholar
  24. 24.
    Gerson SL, Talbot GH, Hurwitz S, Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia Ann Intern Med 1984, 100:345–351 Google Scholar
  25. 25.
    Young RC, Bennet JE, Vogel CL, Aspergillosis: the spectrum of the disease in 98 patients. Medicine 1970, 49:147–173.Google Scholar
  26. 26.
    Meyer RD, Young LS, Armstrong D, Yu B: Aspergillosis complicating neoplastic disease. Am J Med 1983, 54: 6–15.CrossRefGoogle Scholar
  27. 27.
    Groll AH, Renz S, Gerein V, et al.: Fatal haemoptysis associated with invasive pulmonary aspergillosis treated with high-dose amphotericin B and granulocyte macrophage colony-stimulating factor (GM-CSF). Mycoses 1992, 35: 67–75.PubMedCrossRefGoogle Scholar
  28. 28.
    Caillot D, Casasnovas 0, Bernard A,: Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomography scan and surgery. J Clin Oncol 1997, 15: 139–147.PubMedGoogle Scholar
  29. 29.
    Khan FW, Jones JM, England DM: The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986, 86: 518–523.Google Scholar
  30. 30.
    Albelda SM, Talbot GH, Gerson SL, Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1984, 76:1027–1034.Google Scholar
  31. 31.
    McWhinney PHM, Kibbler CC, Hamon MD, Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years experience. Clin Infect Dis 1993, 17:397–404.Google Scholar
  32. 32.
    Yu VL, Muder RR, Poorsattar A: Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: results from a three year prospective study. Am J Med 1986, 81: 249–254.PubMedCrossRefGoogle Scholar
  33. 33.
    Pagani JJ, Libshitz HI: Opportunistic fungal pneumonias in cancer patients. Am J Radiol 1981, 137: 1033–1039.Google Scholar
  34. 34.
    Kuhlman JE, Fishman EK, Siegelman SS: Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985, 157: 611–614.PubMedGoogle Scholar
  35. 35.
    Walmsley S, Devi S, King S, Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J1993,12:673–682.Google Scholar
  36. 36.
    Groll AH, Jaeger G, Allendorf A, Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis in the first three months of life. Clin Infect Dis 1998, 27:437–452.Google Scholar
  37. 37.
    Walsh TJ, Hier DB, Caplan LR: Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985, 18: 574–582.PubMedCrossRefGoogle Scholar
  38. 38.
    Denning DW, Stevens D: Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990, 12: 1147–1201.PubMedCrossRefGoogle Scholar
  39. 39.
    Boes B, Hahn F, Bashir R, et al.: Central nervous system aspergillosis: analysis of 26 patients. J Neuroimag 1994, 4: 123–129.Google Scholar
  40. 40.
    Walsh TJ, Hutchins GM, Bulkley BH, Mendelsohn G: Fungal infections of the heart: analysis of 51 autopsy cases. Am J Cardiol 1980, 45: 357–366.PubMedCrossRefGoogle Scholar
  41. 41.
    Mullen P, Jude C, Borkon M, et al.: Aspergillus mural endocarditis: clinical and echocardiographic diagnosis. Chest 1986, 90: 451–452.PubMedCrossRefGoogle Scholar
  42. 42.
    Groll AH, Walsh TJ: Potential new antifungal agents. Curr Opin Infect Dis 1997, 10: 449–458.CrossRefGoogle Scholar
  43. 43.
    Denning DW, Lee JY, Hostetler JS, et al.: NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994, 97: 135–144.PubMedCrossRefGoogle Scholar
  44. 44.
    White MH, Anaissie EJ, Kusne S, et al.: Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis 1997, 24: 635–642.PubMedGoogle Scholar
  45. 45.
    Walsh TJ, Hiemenz JW, Seibel N. et al.: Amphotericin B lipid complex in invasive fungal infections: analysis of safety and efficacy in 556 cases [Abstr P-571]. Abstracts of the 13th Congress of the International Society for Human and Animal Mycology. Parma, Italy: International Society for Human and Animal Mycology, 1997.Google Scholar
  46. 46.
    Wingard JR: Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses. Bone Marrow Transplant 1997, 19: 343–347.PubMedCrossRefGoogle Scholar
  47. 47.
    Hiemenz JW, Lister EJ, Anaissie E, Emergency use of amphotericin B lipid complex (ABLC) in the treatment of patients with aspergillosis: historical control comparison with amphotericin B. Blood 1995, 86 (suppl 1):849a.Google Scholar
  48. 48.
    Ringden 0, Meunier F, Tollemar J, et al.: Efficacy of amphotericin B encapsulated in liposome (AmBisomeTM) in the treatment of invasive fungal infections in immunocompromised patients. JAntimicrob Chem other 1991, 28 (suppl B): 73–82.CrossRefGoogle Scholar
  49. 49.
    Roilides E, Uhlig K, Venzon D, et al.: Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993, 61: 4870–4877.PubMedGoogle Scholar
  50. 50.
    Walsh TJ, Dixon DM: Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur J Epidemiol 1989, 5: 131–142.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Andreas H. Groll
  • Thomas J. Walsh

There are no affiliations available

Personalised recommendations